Testing of antibiotic releasing implant coatings to fight bacteria in combat-associated osteomyelitis – an in-vitro study

International Orthopaedics

Volumn 40, Issue 5, 2016, Pages 1039-1047

  Back, David Alexander ^a,b   Bormann, Nicole ^b   Calafi, Arash ^c   Zech, Julie ^d,e   Garbe, Leif Alexander ^d,e   Müller, Martin ^f   Willy, Christian ^a   Schmidmaier, Gerhard ^g   Wildemann, Britt ^b  

^a Bundeswehr Hospital Berlin   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^e Central Laboratory   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antibiotics; Bacteria; Combat injury; Implant coating; Orthopaedic infections; Osteomyelitis; PDLLA

Indexed keywords

CEFOXITIN; CIPROFLOXACIN; COLISTIN; DAPTOMYCIN; GENTAMICIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG COATING; DRUG RELEASE; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; KIRSCHNER WIRE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOBLAST; OSTEOMYELITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; BACTERIUM; BATTLE INJURY; BONE WIRE; CELL CULTURE TECHNIQUE; MICROBIOLOGY; PROSTHESES AND ORTHOSES;

ANTI-BACTERIAL AGENTS; BACTERIA; BONE WIRES; CELL CULTURE TECHNIQUES; HUMANS; IN VITRO TECHNIQUES; OSTEOMYELITIS; PROSTHESES AND IMPLANTS; WAR-RELATED INJURIES;

EID: 84959178535     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-016-3142-2     Document Type: Article

References (28)

1. Belmont PJ, Schoenfeld AJ, Goodman G (2010) Epidemiology of combat wounds in Operation Iraqi Freedom and Operation Enduring Freedom: orthopaedic burden of disease. J Surg Orthop Adv 19(1):2–7
2. Yun HC, Branstetter JG, Murray CK (2008) Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma 64(2):163–168
3. Hospenthal DR, Murray CK, Andersen RC, Bell RB, Calhoun JH, Cancio LC, Cho JM, Chung KK, Clasper JC, Colyer MH, Conger NG, Costanzo GP, Crouch HK, Curry TK, D'Avignon LC, Dorlac WC, Dunne JR, Eastridge BJ, Ficke JR, Fleming ME, Forgione MA, Green AD, Hale RG, Hayes DK, Holcomb JB, Hsu JR, Kester KE, Martin GJ, Moores LE, Obremskey WT, Petersen K, Renz EM, Saffle JR, Solomkin JS, Sutter DE, Tribble DR, Wenke JC, Whitman TJ, Wiesen AR, Wortmann GW, Infectious Diseases Society of A, Surgical Infection S (2011) Executive summary: guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society. J Trauma 71(2):202–209
4. Lazzarini L, De Lalla F, Mader JT (2002) Long bone osteomyelitis. Curr Infect Dis Rep 4(5):439–445
5. Murray CK, Hsu JR, Solomkin JS, Keeling JJ, Andersen RC, Ficke JR, Calhoun JH (2008) Prevention and management of infections associated with combat-related extremity injuries. J Trauma 64(3):239–251
6. Sasaki S, Ishii Y (1999) Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. J Orthop Sci 4(5):361–369
7. Buchholz HW, Engelbrecht H (1970) Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41(11):511–515
8. Randelli P, Evola FR, Cabitza P, Polli L, Denti M, Vaienti L (2010) Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 18(2):181–186
9. Sorger JI, Kirk PG, Ruhnke CJ, Bjornson SH, Levy MS, Cockrin J, Tang P (1999) Once daily, high dose versus divided, low dose gentamicin for open fractures. Clin Orthop Relat Res 366:197–204
10. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN (2009) Emerging infections in burns. Surg Infect (Larchmt) 10(5):389–397
11. Hoff SF, Fitzgerald RH Jr, Kelly PJ (1981) The depot administration of penicillin G and gentamicin in acrylic bone cement. J Bone Joint Surg Am 63(5):798–804
12. Diefenbeck M, Muckley T, Hofmann GO (2006) Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury 37(2):95–104
13. Vielgut I, Sadoghi P, Wolf M, Holzer L, Leithner A, Schwantzer G, Poolman R, Frankl B, Glehr M (2015) Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: When is the best time to perform the second stage? Int Orthop 39(9):1731–1736
14. Duewelhenke N, Krut O, Eysel P (2007) Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob Agents Chemother 51(1):54–63
15. Peach CA, Nicoletti S, Lawrence TM, Stanley D (2013) Two-stage revision for the treatment of the infected total elbow arthroplasty. Bone Joint J 95(12):1681–1686
16. Fuchs T, Stange R, Schmidmaier G, Raschke MJ (2011) The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthop Trauma Surg 131(10):1419–1425
17. Strobel C, Schmidmaier G, Wildemann B (2011) Changing the release kinetics of gentamicin from poly(D, L-lactide) implant coatings using only one polymer. Int J Artif Organs 34(3):304–316
18. Kallala R, Graham SM, Nikkhah D, Kyrkos M, Heliotis M, Mantalaris A, Tsiridis E (2012) In vitro and in vivo effects of antibiotics on bone cell metabolism and fracture healing. Expert Opin Drug Saf 11(1):15–32
19. Strobel C, Kadow-Romacker A, Witascheck T, Schmidmaier G, Wildemann B (2011) Evaluation of process parameter of an automated dip-coating. Mater Lett 65:3621–3624
20. Bormann N, Schwabe P, Smith MD, Wildemann B (2014) Analysis of parameters influencing the release of antibiotics mixed with bone grafting material using a reliable mixing procedure. Bone 59:162–172
21. Kadow-Romacker A, Greiner S, Schmidmaier G, Wildemann B (2013) Effect of beta-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. J Biomater Appl 27(5):577–585
22. Kim H, Burgess DJ (2002) Effect of drug stability on the analysis of release data from controlled release microspheres. J Microencapsul 19(5):631–640
23. Taha M, Chai F, Blanchemain N, Neut C, Goube M, Maton M, Martel B, Hildebrand HF (2014) Evaluation of sorption capacity of antibiotics and antibacterial properties of a cyclodextrin-polymer functionalized hydroxyapatite-coated titanium hip prosthesis. Int J Pharm 477(1–2):380–389
24. Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC (2011) Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res 29(7):1070–1074
25. Bieler D, Franke A, Willms A, Hentsch S, Kollig E (2014) Masquelet technique for reconstruction of osseous defects in a gunshot fracture of the proximal thigh—a case study. Mil Med 179(9):1053–1058
26. Fölsch C, Federmann M, Kuehn KD, Kittinger C, Kogler S, Zarfel G, Kerwat M, Braun S, Fuchs-Winkelmann S, Paletta JR, Roessler PP (2015) Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model. Int Orthop 39(5):981–988
27. Madubueze CC, Umaru H, Alada A (2015) Attitudes of Nigerian orthopaedic surgeons to the use of prophylactic antibiotics. Int Orthop 39(11):2161–2165
28. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Biodegradable poly(D, L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 58(4):449–455